GlassScriptPhysician profile
Guy M Mckhann
NPI 1427199058
$24,590.85
in general payments reported to CMS, 2019-2025
13 companies · $30.66 in 2025
The $30.66 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,784 · 2020: $5,200 · 2021: $3,334 · 2022: $2,830 · 2023: $9,926 · 2024: $486 · 2025: $30.66.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,112 · Food and Beverage: $2,226 · Travel and Lodging: $2,104.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,112.00 |
| Food and Beverage | $2,226.35 |
| Travel and Lodging | $2,104.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neuroone Medical Technologies Corporation | $9,556.09 | 2021-2023 | |
| Medtronic USA, INC. | $7,844.74 | 2019-2020 | |
| Dixi Medical USA Corp | $5,913.55 | 2021-2023 | |
| Omniscient Neurotechnology America LTD | $400.00 | 2021 | |
| Neuropace, INC. | $202.73 | 2019-2024 | |
| Jazz Pharmaceuticals INC. | $155.46 | 2022 | |
| Insightec,INC | $145.51 | 2024 | Exablate |
| Novocure INC. | $133.81 | 2024 | Optune |
| Boston Scientific Corporation | $117.52 | 2019-2021 | |
| Medtronic, INC. | $32.16 | 2024 | Visualase |
| Stryker Corporation | $31.66 | 2021 | |
| Monteris Medical Corporation | $30.66 | 2025 | Neuroblate |
| Abbott Laboratories | $26.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Guy Mckhann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.